• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,616.40 47.01
( 0.06%)
Global Indices
Nasdaq
52,658.24 149.83
(0.29%)
Dow Jones
7,594.79 30.15
(0.40%)
Hang Seng
67,217.35 -1,340.38
(-1.96%)
Nikkei 225
10,494.06 -3.23
(-0.03%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

3C IT Solutions & Telecoms (India) Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
544190
INE0R7D01018
22.0598007
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
16.93
9.78
EPS(TTM)
Face Value()
Div & Yield %
0.96
5
0
 

Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13